CURE® TV

With CURE TV®, you have access to a variety of informative and uplifting videos. You’ll find interviews with cancer experts, advocates, patients, caregivers, as well as highlights from our celebratory events showcasing interviews with award winners and celebrity speakers.

An Expert Explains The Risk and Outcomes of Primary Urothelial Cancer Treatment

February 17th 2025, 5:00pm

Video

Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.

Treatment Intensification Adoption Differences Across Prostate Cancer

February 16th 2025, 7:00pm

Video

There are differences in prostate cancer treatment intensification adoption between academic and nonacademic physicians.

Bavencio Has Efficacy in The Real-World Treatment of Urothelial Cancer

February 15th 2025, 6:00pm

Article

Following treatment with Bavencio, patients with urothelial cancer lived for 17 months and their cancer remained stable for nine months.

Understanding How One Must Interpret PSA Levels in Prostate Cancer

February 14th 2025, 10:00pm

Video

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression.

An Expert Explains Updated Data For Patients With GU Cancers

February 13th 2025, 9:35pm

Video

Dr. Guru P Sonpavde discusses updated data from studies like EV-302 and CheckMate 274 for patients with urothelial cancer at the 2025 ASCO GU meeting.

Breaking Down the Implications of Calquence Combination Therapy in MCL

February 13th 2025, 2:00pm

Video

Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in previously untreated mantle cell lymphoma.

Empowering Patients and Advocating For Yourself After Cervical Cancer

February 12th 2025, 5:00pm

Video

Dr. Ritu Salani discusses how patients with cervical cancer can advocate for their health and collaborate with their medical team to ensure the best care.

An Expert Explains the Enhertu Approval in HER2-Low and -Ultralow Breast Cancer

February 12th 2025, 2:00pm

Video

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

Breaking Down The Importance of Targeted Therapies in Colorectal Cancer Care

February 11th 2025, 8:00pm

Video

Dr. Suneel Kamath discusses the ALASCCA study in colorectal cancer and highlighted the importance of next-generation sequencing and testing.

Explaining KRAS Mutations For Patients With Colorectal Cancer

February 11th 2025, 5:00pm

Video

Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.